Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aurora Cannabis Inc. (ACB) vs Siga Technologies Inc. (SIGA)

Aurora Cannabis Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. is the larger, with a market value of $267.8M against $233.5M — 1.1× the size. Aurora Cannabis Inc. grew revenue faster over the last twelve months: −18.2% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −38.1%) and the lower return on invested capital (−14.6% vs −5.58%). Across the 19 metrics below, Siga Technologies Inc. leads on 10 and Aurora Cannabis Inc. on 9.

Valuation

Metric ACB SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.20 4.61 2.25
P/B 0.66 1.50 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.96 2.45 2.56
Earnings yield (34.39%) (1.16%) (2.99%)
Free cash flow yield (14.28%) (8.29%) 0.00%

Profitability

Metric ACB SIGA Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 54.35% 53.94%
Operating margin (12.13%) (20.76%) 0.00%
Net margin (38.12%) (5.19%) 0.00%
Free cash flow margin (17.19%) (37.58%) 0.00%
Return on equity (19.85%) (1.49%) (0.40%)
Return on assets (15.19%) (1.36%) (3.32%)
Return on invested capital (5.58%) (14.59%) 0.00%

Growth

Metric ACB SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) (70.13%) 10.01%
EPS growth (last fiscal year) (5,266.67%) (60.98%) —
Revenue growth, 5-year CAGR 3.92% (5.42%) 6.74%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric ACB SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.00 0.05
Current ratio 5.36 21.72 2.31
Net debt to EBITDA 5.11 (6.39) 0.85

Dividend

Metric ACB SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ACB SIGA Drug Manufacturers Specialty & Generic median
Market cap 267.79m 233.51m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack